Slow Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.67M Sell
11,217
-319
-3% -$244K 1.13% 22
2025
Q4
$8.9M Sell
11,536
-1,002
-8% -$680K 1.06% 26
2025
Q3
$7.05M Buy
12,538
+129
+1% +$72.9K 0.83% 30
2025
Q2
$6.51M Sell
12,409
-7,071
-36% -$3.95M 0.8% 34
2025
Q1
$12.4M Buy
19,480
+6,715
+53% +$4.62M 1.65% 17
2024
Q4
$9.09M Buy
12,765
+410
+3% +$344K 1.29% 17
2024
Q3
$13M Buy
12,355
+241
+2% +$268K 1.99% 14
2024
Q2
$12.7M Buy
12,114
+74
+0.6% +$71.7K 2.06% 14
2024
Q1
$11.6M Buy
12,040
+196
+2% +$186K 1.86% 14
2023
Q4
$10.4M Buy
11,844
+47
+0.4% +$38.7K 1.81% 14
2023
Q3
$9.71M Buy
11,797
+208
+2% +$163K 1.78% 14
2023
Q2
$8.33M Sell
11,589
-167
-1% -$129K 1.45% 15
2023
Q1
$9.66M Buy
11,756
+150
+1% +$113K 1.81% 12
2022
Q4
$8.37M Buy
11,606
+307
+3% +$227K 1.86% 12
2022
Q3
$7.78M Buy
11,299
+1,118
+11% +$704K 1.68% 13
2022
Q2
$6.02M Buy
10,181
+3,040
+43% +$1.98M 1.46% 13
2022
Q1
$4.99M Buy
7,141
+3,179
+80% +$2.01M 0.93% 20
2021
Q4
$2.5M Buy
3,962
+533
+16% +$328K 0.43% 84
2021
Q3
$2.08M Sell
3,429
-346
-9% -$215K 0.38% 92
2021
Q2
$2.11M Buy
3,775
+251
+7% +$127K 0.4% 91
2021
Q1
$1.9M Buy
3,524
+897
+34% +$437K 0.41% 91
2020
Q4
$1.27M Buy
2,627
+242
+10% +$131K 0.3% 115
2020
Q3
$1.33M Buy
2,385
+80
+3% +$48.5K 0.36% 104
2020
Q2
$1.44M Sell
2,305
-67
-3% -$38K 0.42% 91
2020
Q1
$1.16M Buy
2,372
+288
+14% +$119K 0.44% 91
2019
Q4
$782K Buy
2,084
+1,153
+124% +$388K 0.24% 125
2019
Q3
$258K Buy
+931
New +$275K 0.09% 155
2019
Q2
Sell
-2,213
Closed -$909K 172
2019
Q1
$909K Buy
2,213
+42
+2% +$17.3K 0.36% 93
2018
Q4
$811K Buy
2,171
+304
+16% +$111K 0.39% 86
2018
Q3
$754K Buy
1,867
+60
+3% +$22.8K 0.34% 96
2018
Q2
$623K Sell
1,807
-308
-15% -$96.3K 0.32% 99
2018
Q1
$728K Buy
2,115
+638
+43% +$222K 0.33% 100
2017
Q4
$555K Buy
+1,477
New +$598K 0.29% 102

Other funds holding REGN